Gallbladder cancer: can newer insights improve the outcome?

scientific article published on April 2012

Gallbladder cancer: can newer insights improve the outcome? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1440-1746.2011.07048.X
P698PubMed publication ID22168580
P5875ResearchGate publication ID51877481

P2093author name stringUsha Dutta
P2860cites workConsideration of anatomical structures relevant to the surgical strategy for managing gallbladder carcinoma.Q30375639
Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder.Q31146348
Biliary tract cancers.Q33760399
Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in ChinaQ33814914
Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic studyQ33827569
Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updatesQ34186338
Epidemiology and molecular pathology of gallbladder cancerQ34473041
Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North IndiaQ34602274
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancerQ34618537
Nutrition and the immune system from birth to old age.Q34763499
Strategies for surgical treatment of gallbladder carcinoma based on information available before resectionQ35177785
Current management of gallbladder carcinomaQ35583920
Gallbladder cancer: lessons from a rare tumourQ35877178
Gallbladder cancer worldwide: geographical distribution and risk factorsQ36362499
Application of modern imaging methods in diagnosis of gallbladder cancerQ36488822
Preneoplastic lesions in gallbladder cancerQ36488825
Surgical strategies in patients with gallbladder cancer: nihilism to optimismQ36488853
Diagnosis and surgical management of gallbladder cancer: a reviewQ36806456
Emerging drugs for biliary cancerQ36989921
The production of oxysterols in bile by activated human leukocytesQ37067300
Systemic therapy for biliary tract cancersQ37151623
Gallbladder carcinoma update: multimodality imaging evaluation, staging, and treatment optionsQ37305176
A review of the surgical strategies for the management of gallbladder carcinoma based on T stage and growth type of the tumourQ37406450
Endoscopic ultrasound in the evaluation of radiologic abnormalities of the liver and biliary treeQ37413479
Diagnosis of biliary tract and ampullary carcinomasQ37478201
Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatmentQ37478218
Gallbladder cancer: a morphological and molecular update.Q37505245
Management of gallbladder cancerQ37755758
Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunitiesQ37833005
Diagnosis of gallbladder tumorsQ37882943
Epidemiology of biliary tract cancers: an updateQ38455094
Gallbladder cancer: incidence and survival in a high-risk area of ChileQ39933588
Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladderQ40625152
A new method to establish the rational extent of hepatic resection for advanced gallbladder cancer using dye injection through the cystic arteryQ42038384
Targeted medical therapy of biliary tract cancer: recent advances and future perspectivesQ42635172
p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitisQ42863233
Expression of human telomerase catalytic protein in gallbladder carcinogenesisQ43009940
Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinomaQ43207600
Carcinoma of the gallbladder. Staging, treatment, and prognosisQ44360709
Differential diagnostic and staging accuracies of high resolution ultrasonography, endoscopic ultrasonography, and multidetector computed tomography for gallbladder polypoid lesions and gallbladder cancerQ44933250
Childbearing, breastfeeding, other reproductive factors and the subsequent risk of hospitalization for gallbladder diseaseQ45016704
Do the progesterone receptors have a role to play in gallbladder cancer?Q45275928
Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic diseaseQ46112186
Endoscopic ultrasound-guided FNA biopsy of bile duct and gallbladder: analysis of 53 casesQ46897487
Endoscopic retrograde cholangiopancreatography in the evaluation of anomalous junction of the pancreaticobiliary duct and related disordersQ47230253
The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ.Q50154059
Gallbladder cancer in India: a dismal pictureQ50157876
The natural history of gallstones: the GREPCO experience. The GREPCO GroupQ50175791
Gallbladder polyps: how to pick up the sinister onesQ50180813
Heparanase and gallbladder cancer: new insights into understanding tumor growth and invasionQ50186190
Metaplasia and precursor lesions of gallbladder carcinoma. Frequency, distribution, and probability of detection in routine histologic samplesQ50186481
Advanced gallbladder cancer: Indian "middle path".Q50189853
Helicobacter pylori in areas of gastric metaplasia in the gallbladder and isolation of H. pylori DNA from gallstones.Q50466381
β-Glucuronidase Catalyzed Hydrolysis of Benzo[ a ]pyrene-3-Glucuronide and Binding to DNAQ53587057
Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment.Q54331175
Gallbladder cancerQ57646726
Gallbladder carcinomaQ57823528
P433issue4
P921main subjectgallbladder cancerQ977787
P304page(s)642-653
P577publication date2012-04-01
P1433published inJournal of Gastroenterology and HepatologyQ15764401
P1476titleGallbladder cancer: can newer insights improve the outcome?
P478volume27

Reverse relations

cites work (P2860)
Q3596277920(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway
Q36498478A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?
Q40492655A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population
Q34540184Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent
Q53248168BCL6 overexpression is associated with decreased p19 ARF expression and confers an independent prognosticator in gallbladder carcinoma.
Q30402990Clinical, pathological and sonographic characteristics of unexpected gallbladder carcinoma.
Q45032809Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression
Q36132324Diagnosis and management of gallbladder cancer
Q40226063Diagnostic nomogram for gallbladder wall thickening mimicking malignancy: using contrast-enhanced ultrasonography or multi-detector computed tomography?
Q102206684Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex/ hemin enzyme
Q47649561Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines
Q64234361Fine-needle aspiration cytology of gallbladder with an attempt of cytomorphological classification
Q26784174Gallbladder Cancer in the 21st Century
Q57653775Gallbladder cancer
Q37635412Gallbladder cancer: epidemiology and outcome
Q43169383Gallbladder carcinoma: Prognostic factors and therapeutic options
Q40808689IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients
Q96165904MUC16 C-terminal binding with ALDOC disrupts the ability of ALDOC to sense glucose and promotes gallbladder carcinoma growth
Q35627069MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma
Q50592271MicroRNA signatures in total peripheral blood of gallbladder cancer patients.
Q99638639Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by downregulating PRKCE
Q38989068PCBP1 is an important mediator of TGF-β-induced epithelial to mesenchymal transition in gall bladder cancer cell line GBC-SD.
Q92638951PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway
Q50178069Predictors of incidental gallbladder cancer in elderly patients.
Q33594961Proteomic identification of tumor biomarkers associated with primary gallbladder cancer
Q37501085Response of BRCA1-mutated gallbladder cancer to olaparib: A case report
Q51318134Risk factors for gallbladder cancer: a case-control study.
Q26744704Role of laparoscopy in hepatobiliary malignancies
Q99407136Silencing ARAF Suppresses the Malignant Phenotypes of Gallbladder Cancer Cells
Q58101146Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review
Q89768092TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway
Q33613734Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo
Q52669353Tea polyphenols induce S phase arrest and apoptosis in gallbladder cancer cells.
Q96647193The lnc-CITED2-2:1 inhibits metastasis via inhibiting CITED2 and epithelial-mesenchymal transition in gallbladder cancer
Q37694682The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer
Q99411163Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway
Q91678651Up-regulated microRNA-33b inhibits epithelial-mesenchymal transition in gallbladder cancer through down-regulating CROCC
Q39078312WW domain containing oxidoreductase induces apoptosis in gallbladder-derived malignant cell by upregulating expression of P73 and PUMA.
Q64121611aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1